CTX-GLS 500mg Injection
Marketer
GLS Pharma Ltd.
Salt Composition
Cyclophosphamide (500mg)
Overview CTX-GLS 500mg Injection
Cegliximab 500mg injection treats various cancers and, in children, nephrotic syndrome unresponsive to other therapies. Its use for other conditions is at the physician's discretion. Administered intravenously by a healthcare provider, ideally at the same time daily, dosage and frequency depend on the condition and may adjust over time. Strictly adhere to your doctor's instructions; incorrect usage or overdose may cause severe adverse reactions. Benefits might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects, including nausea, vomiting, alopecia, pyrexia, and hematuria, should be reported if persistent or worsening; mitigation strategies exist. This potent medication carries a risk of serious adverse events, potentially impairing immune function and affecting hematological, hepatic, or renal systems; regular blood monitoring is vital. Increased fluid intake promotes urinary excretion, safeguarding kidney and bladder health. Inform your physician of pre-existing liver or kidney disease, and all other medications (including anti-infectives), as interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners during treatment.
Uses of CTX-GLS 500mg Injection
Malignancy | Nephrotic disease
Major Benefits of CTX-GLS 500mg Injection:
This medication will be administered by your physician or their qualified nursing staff; self-medication is strictly prohibited.
Common Side effects of CTX-GLS 500mg Injection:
- Vomiting
- Nausea
- Hair loss
- Fever
- Blood in urine
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use CTX-GLS 500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How CTX-GLS 500mg Injection works:
CTX-GLS 500mg Injection is an antineoplastic agent used in cancer treatment. Its mechanism of action involves alkylation, disrupting the DNA and RNA of cancerous cells, thus inhibiting their proliferation and growth. This underlies its anticancer efficacy.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while using CTX-GLS 500mg Injection.
PregnancyCONSULT YOUR DOCTOR
Administering CTX-GLS 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of CTX-GLS 500mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.
DrivingUNSAFE
Administering CTX-GLS 500mg Injection might lead to adverse reactions, potentially impairing driving capabilities. These reactions can include dizziness, blurred vision, or visual disturbances, all of which could negatively impact the ability to operate a vehicle safely.
KidneyCAUTION
For individuals with severe kidney impairment, the administration of CTX-GLS 500mg Injection requires careful consideration. Dosage modification of CTX-GLS 500mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
The 500mg CTX-GLS injection requires careful administration for individuals with hepatic impairment. Dosage modification of the 500mg CTX-GLS injection might be necessary. Physician consultation is advised.
What if you forget to take CTX-GLS 500mg Injection :
NA
Facts to Know About CTX-GLS 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Alkylating Agents (Nitrogen Mustard Class) |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Alkylating compound |
3,018 People bought this recently